βIII-tubulin enhances efficacy of cabazitaxel as compared with docetaxel
Crossref DOI link: https://doi.org/10.1007/s00280-017-3345-2
Published Online: 2017-05-31
Published Print: 2017-07
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Smiyun, Gregoriy
Azarenko, Olga
Miller, Herbert
Rifkind, Alexander
LaPointe, Nichole E.
Wilson, Leslie
Jordan, Mary Ann http://orcid.org/0000-0002-7037-7829
Funding for this research was provided by:
Sanofi
License valid from 2017-05-31